| Combination therapies and their effectiveness in breast cancer treatment MA Mir, BU Haq Nova Science Publishers, 2021 | 17 | 2021 |
| Role of tumor microenvironment in breast cancer and targeted therapies MA Mir, BU Haq Elsevier, 2022 | 12 | 2022 |
| Targeting breast cancer stem cells through retinoids: a new hope for treatment N Jan, S Sofi, H Qayoom, BU Haq, A Shabir, MA Mir Critical Reviews in Oncology/Hematology, 104156, 2023 | 11 | 2023 |
| Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology N Jan, S Sofi, H Qayoom, A Shabir, BU Haq, MA Macha, MA Mir Heliyon, 2024 | 4 | 2024 |
| Decoding the molecular mechanism of stypoldione against breast cancer through network pharmacology and experimental validation H Qayoom, B Alshehri, BU Haq, A Almilaibary, M Alkhanani, MA Mir Saudi Journal of Biological Sciences 30 (12), 103848, 2023 | 3 | 2023 |
| CDK1 dysregulation in breast cancer MA Mir, BU Haq Therapeutic potential of cell cycle kinases in breast cancer, 195-210, 2023 | 2 | 2023 |
| Therapeutic implications of CDKs in breast cancer MA Mir, BU Haq Therapeutic potential of cell cycle kinases in breast cancer, 233-252, 2023 | 2 | 2023 |
| Exploring HMMR as a therapeutic frontier in breast cancer treatment, its interaction with various cell cycle genes, and targeting its overexpression through specific inhibitors A Shabir, H Qayoom, BU Haq, A Abo Mansoor, A Abdelrahim, I Ahmad, ... Frontiers in Pharmacology 15, 1361424, 2024 | 1 | 2024 |
| Targeting p53 misfolding conundrum by stabilizing agents and their analogs in breast cancer therapy: a comprehensive computational analysis BU Haq, H Qayoom, S Sofi, N Jan, A Shabir, I Ahmad, F Ahmad, ... Frontiers in Pharmacology 14, 1333447, 2024 | 1 | 2024 |
| The Antiangiogenic Basis of Metronomic Chemotherapy MA Mir, A Jan, A Shabir, BU Haq Novel Approaches in Metronomic Chemotherapy for Breast Cancer Treatment, 43-57, 0 | 1 | |
| Metronomic Chemotherapy in Combination with an Anti-Cancer Vaccine MA Mir, T Javed, BU Haq Novel Approaches in Metronomic Chemotherapy for Breast Cancer Treatment, 87-98, 2024 | | 2024 |
| Metronomic Chemotherapy for Metastatic Breast Cancer MA Mir, BU Haq, M Chatterjee, K Hooda Novel Approaches in Metronomic Chemotherapy for Breast Cancer Treatment, 120-129, 2024 | | 2024 |
| Metronomic Chemotherapy: A Multitargeted Therapy MA Mir, A Shabir, BU Haq Novel Approaches in Metronomic Chemotherapy for Breast Cancer Treatment, 15-26, 2024 | | 2024 |
| Tight Junctions and Signaling Pathways in Cancer S Khurshid, B UlHaq, S Khursheed, HQ Sadida, T Masoodi, M Singh, ... Tight Junctions in Inflammation and Cancer, 117-144, 2023 | | 2023 |
| Corrigendum: Targeting p53 Misfolding Conundrum by Stabilizing Agents and their Analogues in Breast Cancer Therapy: A comprehensive computational analysis BU Haq, H Qayoom, S Sofi, N Jan, A Shabir, I Ahmad, F Ahmad, ... Frontiers in Pharmacology 15, 1494110, 0 | | |
| Recent Advances in Metronomic Chemotherapy: Nanotechnology-Based Low-Dose Chemotherapy in Breast Cancer MA Mir, BU Haq, N Rashid Novel Approaches in Metronomic Chemotherapy for Breast Cancer Treatment, 153-170, 0 | | |
Dr Manzoor Ahmad MirUniversity of Kashmir在 kashmiruniversity.ac.in 的电子邮件经过验证
